BioNTech SE (BNTX) Inventory (2018 - 2024)
BioNTech SE's Inventory history spans 7 years, with the latest figure at $302.7 million for Q4 2024.
- For Q4 2024, Inventory fell 21.34% year-over-year to $302.7 million; the TTM value through Dec 2024 reached $302.7 million, down 21.34%, while the annual FY2024 figure was $306.6 million, 20.75% down from the prior year.
- Inventory for Q4 2024 was $302.7 million at BioNTech SE, down from $384.9 million in the prior quarter.
- Across five years, Inventory topped out at $574.8 million in Q4 2021 and bottomed at $76.4 million in Q4 2020.
- The 5-year median for Inventory is $384.9 million (2023), against an average of $357.5 million.
- The largest annual shift saw Inventory surged 652.16% in 2021 before it dropped 21.98% in 2022.
- A 5-year view of Inventory shows it stood at $76.4 million in 2020, then soared by 652.16% to $574.8 million in 2021, then fell by 21.98% to $448.5 million in 2022, then dropped by 14.19% to $384.9 million in 2023, then fell by 21.34% to $302.7 million in 2024.
- Per Business Quant, the three most recent readings for BNTX's Inventory are $302.7 million (Q4 2024), $384.9 million (Q4 2023), and $448.5 million (Q4 2022).